Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows from operating activities:    
Net loss $ (383,175) $ (428,736)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense included in - General and administrative costs 12,936
(Increase) decrease in -    
Advances on research and development contract services (43,411)
Accrued interest receivable 14,082 (4,161)
Prepaid expenses and other current assets 11,052 6,656
Increase (decrease) in -    
Accounts payable and accrued expenses 17,378 15,462
Research and development contract liabilities (29,959) 18,435
Net cash used in operating activities (414,033) (379,408)
Cash:    
Net decrease (414,033) (379,408)
Balance at beginning of period 2,598,864 4,273,012
Balance at end of period 2,184,831 3,893,604
Supplemental disclosures of cash flow information:    
Interest
Income taxes